Table 1. Patient and tumor characteristics in South Korean patients.
| No | Age/Sex | Virus | Tumor diagnosis | Max. dia. (cm) | Grade | Vas. Inv. | Peri-T liver |
| 1 | 46/M | B | HCC/CCC | 6.8 | MD | (−) | LC |
| 2 | 56/M | B | HCC | 2.7 | MD | (−) | CH |
| 3 | 47/M | B | HCC | 3.5 | MD | (−) | LC |
| 4 | 57/M | B | HCC | 1.7 | MD | (−) | CH |
| 5 | 55/M | B | HCC | 3.0 | MD | (−) | LC |
| 6 | 67/M | B | HCC | 8.5 | MD | (−) | CH |
| 7 | 61/M | B | HCC | 3.0 | MD | (−) | LC |
| 8 | 37/M | B | HCC | 9.5 | MD | (−) | CH |
| 9 | 53/M | B | HCC | 4.2 | MD | (−) | LC |
| 10 | 57/M | B | HCC | 16.0 | MD | (+) | CH |
| 11 | 42/M | B | HCC | 4.7 | MD | (−) | LC |
| 12 | 50/M | B | HCC | 4.5 | MD | (−) | LC |
| 13 | 41/M | B | HCC | 4.0 | MD | (−) | CH |
| 14 | 44/M | B | HCC | 3.8 | MD | (−) | LC |
| 15 | 69/F | B | HCC | 8.0 | MD | (−) | LC |
| 16 | 45/M | B | HCC | 15.0 | PD | (−) | LC |
| 17 | 55/M | B | HCC | 11.0 | PD | (−) | LC |
| 18 | 43/M | B | HCC | 14.0 | PD | (−) | CH |
| 19 | 22/M | B | HCC | 10.0 | PD | (−) | CH |
| 20 | 67/F | NBNC | HCC | 6.0 | PD | (−) | Normal |
| 21 | 52/M | B | HCC | 5.0 | PD | (+) | LC |
| 22 | 52/M | B | HCC | 5.0 | PD | (+) | LC |
| 23 | 51/M | B | HCC | 3.9 | PD | (+) | LC |
| 24 | 26/F | B | HCC/CCC | 5.0 | PD | (−) | CH |
| 25 | 56/M | B | HCC | 6.0 | PD | (−) | LC |
| 26 | 49/M | B | HCC | 3.4 | PD | (−) | CH |
| 27 | 63/M | B | HCC | 8.0 | PD | (+) | LC |
Abbreviations: B, hepatitis B virus; CH, chronic hepatitis; HCC/CCC, combined hepatocellular carcinoma and cholangiocarcinoma; LC, liver cirrhosis; MD, moderately differentiated; NBNC, non-B, non-C; PD, poorly differentiated; Peri-T, peri-tumor; Vas. Inv., vascular invasion.